Transcatheter Mitral Valve Repair as Bridge Therapy to Heart Transplantation

NCT04293575 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2020-03-26

No results posted yet for this study

Summary

The aim of this study is to report medium-term outcomes after the use of transcatheter mitral valve repair (TMVR) with MitraClip as a bridge therapy to heart transplantation (HTx) in patients with mitral regurgitation (MR) and end-stage heart failure (HF).

Conditions

Interventions

DEVICE

MitraClip

transcatheter MitraClip device (Abbott Vascular, Santa Clara, California)

Sponsors & Collaborators

  • Scientific Institute San Raffaele

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2020-01-01
Completion
2021-06-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04293575 on ClinicalTrials.gov